Home/Filings/4/0001933414-25-000001
4//SEC Filing

Catalys Pacific Fund, LP 4

Accession 0001933414-25-000001

CIK 0001933414other

Filed

Jan 6, 7:00 PM ET

Accepted

Jan 7, 5:58 PM ET

Size

10.5 KB

Accession

0001933414-25-000001

Insider Transaction Report

Form 4
Period: 2024-05-22
Slingsby Brian Taylor
Director10% Owner
Transactions
  • Other

    Stock Option

    2024-05-2222,0000 total
    Exercise: $12.52Exp: 2034-05-22Common Stock (22,000 underlying)
  • Other

    Stock Option

    2024-05-22+22,00022,000 total(indirect: See footnote)
    Exercise: $12.52Exp: 2034-05-22Common Stock (22,000 underlying)
Transactions
  • Other

    Stock Option

    2024-05-2222,0000 total
    Exercise: $12.52Exp: 2034-05-22Common Stock (22,000 underlying)
  • Other

    Stock Option

    2024-05-22+22,00022,000 total(indirect: See footnote)
    Exercise: $12.52Exp: 2034-05-22Common Stock (22,000 underlying)
Footnotes (3)
  • [F1]Represents stock options transferred pursuant to an option transfer agreement between the Reporting Person and Catalys Pacific Fund, LP.
  • [F2]The stock option award vests in 12 substantially equal monthly installments beginning on June 22, 2024. In the event that the next annual meeting of stockholders occurs prior to May 22, 2025, any remaining unvested portion of the stock option award will vest on the date of such meeting.
  • [F3]Represents securities held directly by Catalys Pacific Fund, LP. The general partner of Catalys Pacific Fund, LP is Catalys Pacific Fund GP, LP. Brian Taylor Slingsby is the managing partner of Catalys Pacific, LLC, which is the general partner of Catalys Pacific Fund GP, LP. Catalys Pacific, LLC, Catalys Pacific Fund GP, LP and Brian Taylor Slingsby may be deemed to have voting and investment power over the shares held of record by Catalys Pacific Fund, LP. Each of Catalys Pacific, LLC, Catalys Pacific Fund GP, LP and Brian Taylor Slingsby disclaim beneficial ownership of such shares, except to the extent of any pecuniary interest therein.

Issuer

Mineralys Therapeutics, Inc.

CIK 0001933414

Entity typeother
IncorporatedCayman Islands

Related Parties

1
  • filerCIK 0001746274

Filing Metadata

Form type
4
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 5:58 PM ET
Size
10.5 KB